MEMO on a competitiveness strategy for the European healthcare sector
Recommendations to National Authorities on the Use of External Reference Pricing (ERP)
Assessing the Cost Burden of UWWTD Extended Producer Responsibility on Pharmaceuticals: Implications for the accessibility, availability and affordability of medicines
Position paper on the Issue of Abuses of Divisional Patent Applications
Open letter on the Critical Medicines Act trilogues negotiations – The CMA must deliver on EU health security
Technical note on the Joint Research Centre report “Updated estimation of the costs of quaternary wastewater treatment in the EU”
Open letter on the urgent need to pause the UWWTD serious risk of causing tsunami of medicine shortages
Position paper on the Revision of EU Rules on Public Procurement
Product-level Life Cycle Assessments in the Off-Patent Sector
Mandatory Stockpiling in the EU: Policy recommendations, solutions and alternatives
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
